Skip to main content

For Industry

You are here

Company Profiles

  • Breethe Logo

    Breethe, Inc.

    Breethe, Inc. is a product development-stage company spun out of the University of Maryland, Baltimore in 2014 to develop and commercialize the world's first wearable artificial lung. 

    Visit Website ]

    Category:Devices

    Established:

  • Cook Medical Logo

    Cook Medical

    Cook Medical makes 16,000 products that serve 13 hospital lines and provides products to 135 countries.

    Visit Website ]

    Category:Devices

  • Countervail Corporation

    Countervail Corporation

    Countervail Corporation is  focused on providing protection and treatment of military and civilian populations from exposure to chemical and biological weapons. 

    Visit Website ]

    Category:Biologics

    Established:

  • Pax Vax Logo

    PaxVax

    PaxVax is an independent vaccine company with a robust pipeline that brings to market specialty vaccines that protect against existing and emerging infectious diseases.

    Visit Website ]

    Category:Vaccines

    Established:

  • Archimedes Bioengineering, LLC Logo

    Archimedes Bioengineering, LLC

    Archimedes Bioengineering, LLC is a collaborative effort between University of Maryland, College Park (UMCP), Children’s National Medical Center, and a private company. Archimedes is based on a portfolio of patent pending diagnostic technologies that enable the detection of aminoacidopathy disorders such as, Hyperammonemia, Phenylketonuria (PKU), Maple Syrup Urine Disease, and Aminoacidemia which are a group of metabolic disorders that result from the build-up of one or more amino acids in the blood and/or urine. These metabolic disorders may be caused by defects in enzymatic pathways that inhibit the metabolism of the certain amino acids. Using different diagnostic device designs and embodiments, Archimedes hopes to revolutionize the point-of-care market for aminoacidopathy diagnostics. 

    Visit Website ]

    Category:Bioengineering

    Established:

  • ElectroMed, LLC

    ElectroMed, LLC has licensed the Quick-Release Self-Contained Medical Electrode (US Patent 8,897,853) developed by students at the Fischell Department of Bioengineering. This novel electrode achieves five goals in having increased hydrogel adhesiveness, combining the electrode and adhesive remover in a single unit, greatly reducing removal force required, eliminating leftover residue, and whose removal would not compromise local tissues in sensitive skin situations. These properties make the electrode ideal for burn victims and neonates as it strongly adheres to damaged and growing skin while not injuring delicate skin during removal

    Category:Bioengineering

    Established:

  • Otomagnetics Logo

    Otomagnetics, LLC

    A University of Maryland College Park spin-out, is developing a non-invasive method to effectively deliver drugs and other therapeutic payloads to the inner and middle ear.

    Visit Website ]

    Category:Bioengineering

    Established:

  • Sintact Medication Systems

    Sintact Medical Systems, Inc.

    Sintact Medical Systems, Inc. develops non-resorbable films that separate adjacent organs from adhering to each other after surgery. 

    Visit Website ]

    Category:Biomaterials

    Established:

  • Calabash Biosciences

    Calabash Biosciences is based on a technology that uses novel molecular containers for efficient drug delivery applications. These molecular containers first conceived and created by University of Maryland’s (UMCP) investigators improve the solubilization of drugs and allow them to be easily accessed by the body. The enhanced solubilization makes them superior to the currently available cyclodextrixn class of compounds. Calabash was initiated as a follow-up to collaborative research efforts between investigators at the UMCP and Mass General Hospital. Their collaboration involved the study of drug solubilization applications, in particular, the reversal of neuromuscular blocking (NMB) or anesthesia inducing agents. Calabash is in the process of developing new formulations for a variety of currently available drugs in the market. 

    Category:Small molecules

    Established:

  • StemSynergy Logo

    StemSynergy Therapeutics, Inc.

    StemSynergy Therapeutics, Inc. (SSTI) is a biopharmaceutical company focused on the discovery of small-molecule drugs that target developmental pathways fundamental to cancer and tissue regeneration. 

    Visit Website ]

    Category:Small molecules

    Established:

Pages